当前位置: 首页 > 医疗版 > 疾病专题 > 肾脏内科 > 继发性肾脏疾病 > 糖尿病肾病
编号:13505865
人体成分监测在糖尿病肾病血液透析患者营养治疗中应用效果分析(1)
http://www.100md.com 2020年2月15日 《中国现代医生》 20205
     [摘要] 目的 探讨人体成分监测在糖尿病肾病血液透析患者治疗中的应用效果。 方法 选取我院2017年2月~2018年10月收治的120例糖尿病肾病血液透析患者为研究对象,随机分为正常营养组和监测营养组各60例。正常营养组给予一般的饮食指导及营养支持干预。监测营养组结合人体成分分析结果确定专业的营养处方,按照处方进行营养学治疗。治疗4周后比较两组营养学指标水平、血清炎症因子水平、心血管并发症发生率。 结果 监测营养组血清总白蛋白(TP)、清蛋白(ALB)、前白蛋白(PA)、转铁蛋白(TRF)水平均高于正常营养组(P<0.05)。监测营养组C反应蛋白(CRP)、白细胞介素-6(IL-6)、肿瘤坏死因子(TNF-α)低于正常营养组(P<0.05)。监测营养组心血管并发症发生率56.67%低于正常营养组86.67%(P<0.05)。 结论 人体成分检测应用于糖尿病肾病血液透析患者能提高患者营养学指标、降低患者血清炎症因子水平及心血管并发症发生率,值得应用推广。

    [关键词] 人体成分监测;糖尿病肾病;血液透析;营养学指標

    [中图分类号] R692.5;R587.2 [文献标识码] A [文章编号] 1673-9701(2020)05-0013-03

    Analysis of the effect of body composition monitoring in nutritional therapy in patients with diabetic nephropathy and hemodialysis

    AN Chao WANG Lei GAO Siqi LU Yanmin

    Department of Clinical Nutrition, Affiliated Hospital of Binzhou Medical College, Binzhou 256603, China

    [Abstract] Objective To explore the effect of body composition monitoring in the treatment of patients with diabetic nephropathy and hemodialysis. Methods A total of 120 patients with diabetic nephropathy and hemodialysis who were treated in our hospital from February 2017 to October 2018 were selected as the research objects, and they were randomly divided into normal nutrition group and monitoring nutrition group, with 60 cases in each group. Patients in the normal nutrition group were given general dietary guidance and nutritional support interventions. The monitoring nutrition group determined professional nutrition prescriptions combined with the results of body composition analysis and was treated with nutritional treatment according to the prescriptions. After 4 weeks of treatment, the levels of nutritional indicators, serum inflammatory factors, and the incidence ofcardiovascular complications were compared between the two groups. Results The levels of serum total albumin(TP), albumin(ALB), prealbumin(PA), and transferrin(TRF) in the monitoring nutrition group were higher than those in the normal nutrition group(P<0.05). The C-reactive protein(CRP), interleukin-6(IL-6), and tumor necrosis factor(TNF-α) in the monitoring nutrition group were lower than those in the normal nutrition group(P<0.05). The incidence of cardiovascular complications in the monitoring nutrition group was 56.67%, lower than that(86.67%) in the normal nutrition group(P<0.05). Conclusion The application of body composition detection in patients with diabetic nephropathy and hemodialysis can improve the nutritional index of patients, reduce the serum inflammatory factor levels and the incidence of cardiovascular complications. It is worthy of application and promotion., http://www.100md.com(安超 王蕾 高思琪 卢艳敏)
1 2 3下一页


    参见:首页 > 医疗版 > 疾病专题 > 肾脏内科 > 继发性肾脏疾病 > 糖尿病肾病